SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001401914-24-000021
Filing Date
2024-03-29
Accepted
2024-03-29 16:06:27
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 s-3baseprospectus2024march.htm S-3 437453
2 EX-FILING FEES exhibit107_filingfeetables.htm EX-FILING FEES 59541
3 EX-4.10 exhibit410-formofseniorind.htm EX-4.10 375919
4 EX-4.11 exhibit411-formofsubordina.htm EX-4.11 371022
5 EX-5.1 exhibit51legalopinion_s-3x.htm EX-5.1 34492
6 EX-23.1 exhibit231auditorconsents-.htm EX-23.1 3827
7 EX-23.2 exhibit232auditorconsents-.htm EX-23.2 3226
8 darebioinlinefullcolorrgba.jpg GRAPHIC 130914
9 image_1a.jpg GRAPHIC 135
10 image_21a.jpg GRAPHIC 135
  Complete submission text file 0001401914-24-000021.txt   1457003
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278380 | Film No.: 24804174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)